Use of national guidelines for the introduction of Drotrecogin alfa (activated)

Схожие документы

• Audit of adherence to National Institute of Clinical Excellence guidelines for the use of drotrecogin alfa (activated)
  по: Vedantham, R, et al.
  Опубликовано: (2007)
• Increasing microcirculation after drotrecogin alfa (activated)
  по: Donati, A, et al.
  Опубликовано: (2007)
• A large, single-centre UK registry of drotrecogin alfa-activated use
  по: Macchiavello, L, et al.
  Опубликовано: (2007)
• Severe sepsis and drotrecogin alfa (activated) use: results from the PROGRESS registry
  по: Beale, R, et al.
  Опубликовано: (2007)
• Drotrecogin alfa (activated) does not impair platelet receptor expression in vitro
  по: Schuerholz, T, et al.
  Опубликовано: (2004)